Correlation Between Aileron Therapeutics and Akari Therapeutics

Can any of the company-specific risk be diversified away by investing in both Aileron Therapeutics and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aileron Therapeutics and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aileron Therapeutics and Akari Therapeutics PLC, you can compare the effects of market volatilities on Aileron Therapeutics and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aileron Therapeutics with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aileron Therapeutics and Akari Therapeutics.

Diversification Opportunities for Aileron Therapeutics and Akari Therapeutics

-0.07

Correlation Coefficient

Aileron Therapeutics  Akari Therapeutics

Good diversification

The 3 months correlation between Aileron and Akari is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Aileron Therapeutics and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Aileron Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aileron Therapeutics are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Aileron Therapeutics i.e., Aileron Therapeutics and Akari Therapeutics go up and down completely randomly.

Pair Corralation between Aileron Therapeutics and Akari Therapeutics

Given the investment horizon of 90 days Aileron Therapeutics is expected to generate 0.85 times more return on investment than Akari Therapeutics. However, Aileron Therapeutics is 1.18 times less risky than Akari Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Akari Therapeutics PLC is currently generating about -0.21 per unit of risk. If you would invest  270.00  in Aileron Therapeutics on September 2, 2024 and sell it today you would earn a total of  16.00  from holding Aileron Therapeutics or generate 5.93% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Aileron Therapeutics  vs.  Akari Therapeutics PLC

Aileron Therapeutics

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Aileron Therapeutics are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of very inconsistent basic indicators, Aileron Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Akari Therapeutics PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Akari Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Pair Trading with Aileron Therapeutics and Akari Therapeutics

The main advantage of trading using opposite Aileron Therapeutics and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aileron Therapeutics position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.

The idea behind Aileron Therapeutics and Akari Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.